The dynamics of hepatic lipid metabolism in humans: understanding their role in fatty liver disease

The dynamics of hepatic lipid metabolism in humans: understanding their role in fatty liver disease

<p>Non-alcoholic fatty liver disease (NAFLD) has become increasingly prevalent. It is associated with changes in hepatic and whole-body fatty acid (FA) metabolism, with the first stage of the disease, steatosis, characterised by excess triacylglycerol (TAG) storage with a specific (macrovesicu...

Bibliografski detalji
Glavni autor:	Gunn, P
Daljnji autori:	Hodson, L
Format:	Disertacija
Jezik:	English
Izdano:	2018
Teme:	Metabolism Medical sciences NAFLD Lipids

Slični predmeti

Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
od: Ting Li, i dr.
Izdano: (2019-12-01)

Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism
od: Fei-Fei Mao, i dr.
Izdano: (2023-02-01)

Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
od: Chia-Jung Liao, i dr.
Izdano: (2022-05-01)

Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease
od: Lijia Zhang, i dr.
Izdano: (2022-10-01)

Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies
od: Han Zhang, i dr.
Izdano: (2021-11-01)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
od: Yuting Ma, i dr.
Izdano: (2021-12-01)

Metabolic role of the hepatic valine/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver diseaseResearch in context
od: Mona Synnøve Bjune, i dr.
Izdano: (2023-05-01)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
od: Sa Yang, i dr.
Izdano: (2022-07-01)

A potential gateway to understanding liver disease development: peripartum lipid fluctuations in dairy cows
od: Laura Vogel, i dr.
Izdano: (2024-11-01)

Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
od: Jonathan M. Hazlehurst, i dr.
Izdano: (2022-06-01)

A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease
od: Dandan He, i dr.
Izdano: (2021-11-01)

Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis
od: Pippa J. Gunn, i dr.
Izdano: (2020-07-01)

The Absence of STING Ameliorates Non-Alcoholic Fatty Liver Disease and Reforms Gut Bacterial Community
od: Qiang Zhang, i dr.
Izdano: (2022-06-01)

Metabolic Syndrome in Adults with Nonalcoholic Fatty Liver Disease
od: Zhahid Hassan, i dr.
Izdano: (2021-09-01)

Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction
od: Yuhan Cao, i dr.
Izdano: (2022-06-01)

Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice
od: Fang Xie, i dr.
Izdano: (2022-11-01)

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
od: Francesco Massimo Perla, i dr.
Izdano: (2017-06-01)

Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders
od: Maojun Cheng, i dr.
Izdano: (2025-01-01)

Nobiletin Intake Attenuates Hepatic Lipid Profiling and Oxidative Stress in HFD-Induced Nonalcoholic-Fatty-Liver-Disease Mice
od: Zunli Ke, i dr.
Izdano: (2023-03-01)

Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease
od: Yahui Wen, i dr.
Izdano: (2023-08-01)

Role of hepatic deiodinases in thyroid hormone homeostasis and liver metabolism, inflammation, and fibrosis
od: Eveline Bruinstroop, i dr.
Izdano: (2023-04-01)

Dietary pattern and hepatic lipid metabolism
od: Peng Zou, i dr.
Izdano: (2023-12-01)

Metabolic dysfunction: The silenced connection with fatty liver disease
od: Mariana M. Ramírez-Mejía, i dr.
Izdano: (2023-11-01)

Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
od: Claudia Theys, i dr.
Izdano: (2024-01-01)

Is the Fatty Acids Profile in Blood a Good Predictor of Liver Changes? Correlation of Fatty Acids Profile with Fatty Acids Content in the Liver
od: Dominika Maciejewska, i dr.
Izdano: (2019-11-01)

Hepatic Macrophage as a Key Player in Fatty Liver Disease
od: Liyun Xu, i dr.
Izdano: (2021-12-01)

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review
od: Panayiotis Kouis, i dr.
Izdano: (2014-05-01)

Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
od: Douglas G. Mashek
Izdano: (2021-08-01)

MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice
od: Shu Fang, i dr.
Izdano: (2020-01-01)

MLN4924 Treatment Diminishes Excessive Lipid Storage in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) by Stimulating Hepatic Mitochondrial Fatty Acid Oxidation and Lipid Metabolites
od: Mengxiao Ge, i dr.
Izdano: (2022-11-01)

Hepatic lipid metabolism is altered in Ubiad1 +/− mice of both sexes
od: Ryoko Higa, i dr.
Izdano: (2025-02-01)

Non-Alcoholic fatty liver disease and metabolic syndrome in patients with HIV/AIDS and its correlation with antiretroviral therapy and severity of disease
od: P. K. Gupta, i dr.
Izdano: (2023-08-01)

The role of FOXA family transcription factors in glucolipid metabolism and NAFLD
od: Chuchu Yu, i dr.
Izdano: (2023-01-01)

TDO2 deficiency attenuates the hepatic lipid deposition and liver fibrosis in mice with diet-induced non-alcoholic fatty liver disease
od: Zhi Qin, i dr.
Izdano: (2023-11-01)

Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents
od: Justin Chin, i dr.
Izdano: (2020-12-01)

Metabolism of lipid in the human fatty streak lesion
od: Aram V. Chobanian, i dr.
Izdano: (1972-03-01)

Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro
od: Hyun Hwangbo, i dr.
Izdano: (2020-10-01)

IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism
od: Yongqiang Ma, i dr.
Izdano: (2022-07-01)

Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis
od: Song Lu, i dr.
Izdano: (2023-03-01)

Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells♦
od: Ylse Gutiérrez-Grabe, i dr.
Izdano: (2013-11-01)